Company Overview and News

 
Oil import bill rises over 34% in first half on weak peso

2018-09-20 bworldonline
THE OIL IMPORT bill rose by 34.4% in the first half to $6.312 billion, in part due to a depreciating peso, making shipments of crude oil and finished petroleum products more expensive.
PNX PNX3B PNXP PNX3A

 
Dennis Uy gobbles up restaurant chain Conti’s

2018-09-10 bworldonline
DAVAO-BASED businessman Dennis A. Uy is acquiring a majority stake in the owner and operator of popular restaurant chain Conti’s, as he continues to diversify his investments.
PNX PNX3B PNXP PNX3A

 
Fuel prices up P0.65/L this week

2018-09-10 bworldonline
OIL COMPANIES are raising the prices of petroleum products this week by P0.65 per liter (/L) for gasoline, diesel and kerosene. All of the companies that sent their advisories will be adjusting prices at 6:00 a.m. on Sept. 10. This week’s hike is the fifth straight week of increases for gasoline products. It follows last week’s hefty P0.95/L hike, which was the highest rise since end-July. It is also the fourth consecutive price increase for kerosene and the third for diesel.
PNX PNX3B PNXP PNX3A

 
State-led PNOC seeks partners for integrated LNG hub project

2018-08-30 bworldonline
STATE-LED PHILIPPINE National Oil Co. (PNOC) is seeking partners to build an integrated liquefied natural gas (LNG) hub under new terms that defines the project under a “solicited” scheme, after the government agency failed to attract acceptable proponents.
PNX ITOCY PNX3B PNXP PNX3A KEP ITOCF ATB

 
Phoenix Petroleum second-quarter profit surges 62%

2018-08-08 bworldonline
Phoenix Petroleum Philippines, Inc. reported a net income of P531.11 million in the second quarter, higher by 62% compared with the P327.77 million posted a year ago, as revenues during the period more than doubled with the surge in sales volume.
PNX PNX3B PNXP PNX3A

 
After surge, fuel prices down a bit

2018-08-06 newsinfo.inquirer.net
After hefty price increases over the past five weeks, oil firms will concede on Tuesday a reduction of 10 centavos in the prices of diesel and gasoline.
PNX PNX3B PNXP PNX3A

 
Phoenix expands deal with Cebu Pacific

2018-07-12 bworldonline
PHOENIX Petroleum Philippines, Inc. has expanded its services to Cebu Air, Inc. in two more domestic airports, bringing the total to 17 under their decade-long partnership.
PNX PNX3B PNXP CEBUF PNX3A CEBUY CEB

11
Phoenix expects to be part of CNOOC’s proposed LNG project

2018-06-25 bworldonline
PHOENIX Petroleum Philippines, Inc. expects to be part of the liquefied natural gas (LNG) project being proposed by China National Offshore Oil Corp. (CNOOC), possibly in partnership with state-led Philippine National Oil Co. (PNOC).
PNX PNX3B PNXP PNX3A CEO

5
Phoenix continues network expansion program

2018-06-08 business.inquirer.net
Phoenix Petroleum Philippines Inc. has opened at least seven new filling stations across the country so far this year amid a push to boost its retail network.
PNX PNX3B PNXP PNX3A

32
Phoenix inks deal with CNOOC for LNG project

2018-06-05 bworldonline - 1
PHOENIX Petroleum Philippines, Inc. on Tuesday said it had signed a memorandum of understanding (MoU) with a unit of China National Offshore Oil Corp. (CNOOC) to develop a receiving terminal for imported liquefied natural gas (LNG) in the country.
PNX SMCP1 SMGBY SMGBF SMC2B SMC2A SMC SMC2D PNX3B PNXP SMC2C PNX3A SMC2F SMC2E LNG CEO

50
BusinessWorld Economic Forum 2018 tackles realities of disruption

2018-05-31 bworldonline
Last May 18, BusinessWorld, the most read and most respected business newspaper in the Philippines, triumphantly staged the third edition of its annual BusinessWorld Economic Forum in the Grand Ballroom of Grand Hyatt Manila, in Bonifacio Global City, Taguig City.
MER GTCAP GTCXY SVTMF SMCP1 ABZPY BDOUY SM BDOUF SMGBF SMIVY SMC PNX3B PNXP PNX3A MPCFF PNX UBNC MPCIY SMGBY ABZPF BDO SMC2B SMC2A SMC2D SMC2C MPI SMC2F SMC2E AP LTG

5
Phoenix acquires digital payment platform

2018-05-28 bworldonline
PHOENIX Petroleum Philippines, Inc. has acquired 75% of two companies that own a digital payment platform, which eases the financial transactions between merchants and customers, the oil firm told the stock exchange on Monday.
PNX PNX3B PNXP PNX3A

5
Fuel prices up again this week

2018-05-28 bworldonline
OIL COMPANIES will be raising the prices of petroleum products this week, the third straight week that they will be doing so after a slight decrease during the first week of May. Gasoline prices per liter (/L) will increase by P0.65, while diesel and kerosene will rise by P0.35 and P0.45, respectively. The increase will be implemented at 6:00 a.m. on Tuesday, May 29. Last week, oil companies raised the prices of gasoline, diesel and kerosene at P1.
PNX PNX3B PNXP PNX3A

5
Oil firms announce fuel price hike

2018-05-28 bworldonline
Oil companies will be raising the prices of petroleum products this week, the third straight week that they will be doing so after a slight decrease during the first week of the month.
PNX PNX3B PNXP PNX3A

9
Change or face extinction, businesses told

2018-05-20 bworldonline
This was the message of Udenna Corp. founder, Chairman and Chief Executive Officer Dennis A. Uy in his keynote speech during the BusinessWorld Economic Forum 2018, titled: “Disruptor or Disrupted?” at the Grand Hyatt Manila in Taguig City on Friday last week.
ABZPF PNX UBNC PNX3B PNXP PNX3A ABZPY AP

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...